Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

VR training shows promise for Kids' eye misalignment

NCT ID NCT06117813

Disease control Sponsor: Nunaps Inc Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested a virtual reality training program called Nu.T in 54 children aged 6 to 15 with intermittent exotropia, a condition where one eye occasionally turns outward. Half of the children used the Nu.T software to do visual exercises, while the other half received no treatment. The goal was to see if the training could improve stereopsis, or depth perception. The results could lead to a new, non-invasive option for managing this condition.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Nu.T (visual perceptual training software delivered via virtual reality)
What this could lead to
If it works, this could point toward a non-invasive, drug-free way to improve depth perception in children with intermittent exotropia.
What could go wrong
This is a small, early-stage trial with only 54 participants, and the control group received no treatment. The results may not apply to all patients, and the improvement may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

54 people

The number who actually took part.

Started

Dec 2023

Finished

Jul 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 15 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Intermittent Exotropia patients aged 6 to 15 * Patients with decreased stereopsis above 50 arc seconds in Titmus Dot Test * Able to use the Virtual Reality(VR) device * Patient or legally authorized representative has signed the informed consent form Exclusion Criteria: * Incomitant strabismus patient with impaired eye movement * Patients with amblyopia (Maximal corrective vision of one eye is less than 0.8 or maximal corrective vision both eyes more than two lines of difference) * History of ophthalmic surgery * Patient who has undergone or is currently undergoing cover treatment within one month for the purpose of treating strabismus or amblyopia * Scheduled for ophthalmic surgery during the clinical trial participation period (8 weeks in the treatment group as of the registration date, Maximum 16 weeks in the control group as of the registration date) * Difficult to understand and perform the stereopsis test. * Abnormal Retinal Correspondence * Patient with neurological abnormalities other than strabismus * History of premature birth * Participating in other clinical trial * Any other condition that, in the opinion of the investigator, precludes participation in the trial

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Intermittent exotropia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

alternating exotropia intermittent squint

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Intermittent exotropia

Contacts and locations

Locations

  • Asan Medical Center

    Seoul, South Korea

  • Hangil Eye Hospital

    Incheon, South Korea

  • Inje University Ilsan Paik Hospital

    Goyang, South Korea

  • Konkuk University Hospital

    Seoul, South Korea

  • Nowon Eulji Medical Center, Eulji University

    Seoul, South Korea

  • Uijeongbu Eulji Medical Center, Eulji University

    Uijeongbu-si, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.